AstraZeneca in AI collaboration with Immunai to inform cancer drug ...

AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune system to make ...

AstraZeneca in AI Collaboration With Immunai to Inform Cancer ...

(Reuters) - AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune ...

This is the latest in a string of tie-ups by Anglo-Swedish drugmaker AstraZeneca to use artificial intelligence for drug discovery and ...

Immunai and AstraZeneca's $18 Million AI Collaboration to ...

Immunai and AstraZeneca's $18 million AI collaboration aims to transform cancer drug development and enhance R&D strategies. Immunai Inc., a New ...

AstraZeneca extends AI immuno-oncology R&D pact with Immunai

AstraZeneca is extending its work with Immunai through a multiyear collaboration that aims to implement its artificial-intelligence-powered immune cell atlas.

Israeli AI startup forges $18m partnership with AstraZeneca for ...

Israeli-American biotech unicorn Immunai on Thursday secured a $18 million partnership to help the Anglo-Swedish pharma giant AstraZeneca improve the ...

AstraZeneca invests in AI collaboration for cancer drug trials

AstraZeneca has pledged to pay US$18 million to Immunai in order to use the biotechnology company's AI model of the immune system during certain cancer drug ...

Immunai, AstraZeneca collaborate to optimize cancer clinical trials

Under the terms of the agreement, AstraZeneca will leverage Immunai's platform and machine learning capabilities to inform certain oncology ...

Immunai, AstraZeneca Partner On AI-Powered Immune System ...

The partnership aims to leverage Immunai's proprietary AI model, the IDE, to enhance clinical decision-making and improve the success rates of drug development ...

Newsroom - Immunai

Newsroom (60) · Immunai announces collaboration with AstraZeneca for advanced clinical trial optimization · AstraZeneca extends AI immuno-oncology R&D pact with ...

Immunai announces collaboration with AstraZeneca for ... - WebWire

Immunai, a leading artificial intelligence (AI) biotech company, has pioneered AMICA™, its proprietary immune cell atlas, with multi-omic ...

Immunai and AstraZeneca Collaborate to Optimize Oncology ...

Immunai, a New York-based AI biotech company, has entered a multi-year collaboration with AstraZeneca to optimize oncology clinical trials.

News - Immunai

News (31) · AstraZeneca extends AI immuno-oncology R&D pact with Immunai · AstraZeneca in AI collaboration with Immunai to inform cancer drug trials · Improving ...

AstraZeneca Joins Forces With Immunai In $18 Million AI Deal

AstraZeneca invests in Immunai's AI technology to boost cancer drug trials. ... This collaboration underscores a broader trend of biotech companies harnessing AI ...

The Antibody Society posted on the topic | LinkedIn

AstraZeneca in AI collaboration with Immunai to inform cancer drug trials · More Relevant Posts · Data on over 2,300 Lung Cancer Biomarkers Mapped ...

AstraZeneca Partners with Immunai to Use AI for Enhancing Cancer ...

AstraZeneca has entered into a collaboration with biotech firm Immunai Inc., investing $18 million to utilize Immunai's advanced artificial intelligence (AI) ...

AstraZeneca invests $18 million in Immunai's AI technology

AstraZeneca will initially gain access to Immunai's AI tools to support its cancer research efforts, with the option to extend the collaboration ...

AstraZeneca and Immunai Partner to Boost Cancer Drug Trials with AI

AstraZeneca has entered into a new partnership with New York-based biotechnology firm Immunai to leverage their advanced AI model of the immune system for ...

Israeli mapping company ImmunAI partners with AstraZeneca

... pharmaceutical giant AstraZeneca for the ... The collaboration with AstraZeneca will allow us to harness our IDE™ artificial intelligence ...

Data Science & Artificial Intelligence - AstraZeneca

At AstraZeneca we harness data and technology to maximise time for the discovery and delivery of potential new medicines. Data science and artificial ...